CBD gummies have exploded in popularity as a natural way to experience the benefits of cannabidiol (CBD) without the need for vaping, smoking, or using tinctures.
UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...